A nomenclature for ligand-gated ion channels

Graham L. Collingridge, Richard W. Olsen, John Peters, Michael Spedding

    Research output: Contribution to journalArticle

    376 Citations (Scopus)

    Abstract

    The ligand-gated ion channels that participate in fast synaptic transmission comprise the nicotinic acetylcholine, 5-hydroxytryptamine(3) (5-HT3), gamma-aminobutyric acid(A) (GABA(A)), glycine, ionotropic glutamate and P2X receptor families. A consistent and systematic nomenclature for the individual subunits that comprise these receptors and the receptors that result from their co-assembly is highly desirable. There is also a need to develop criteria that aid in deciding which of the vast number of heteromeric combinations of subunits that can be assembled in heterologous expression systems in vitro, are known, or likely. to exist as functional receptors in vivo. The aim of this short article is to summarize the progress being made by the nomenclature committee of IUPHAR (NC-IUPHAR) in formulating recommendations that attempt to address these issues. (C) 2008 Elsevier Ltd. All rights reserved.

    Original languageEnglish
    Pages (from-to)25
    Number of pages4
    JournalNeuropharmacology
    Volume56
    Issue number1
    DOIs
    Publication statusPublished - Jan 2009

    Keywords

    • Ligand-gated ion channels
    • Nomenclature
    • UNION-OF-PHARMACOLOGY
    • GLUTAMATE RECEPTOR SUBUNIT
    • INTERNATIONAL-UNION
    • MOLECULAR RELATIONSHIPS
    • POTASSIUM CHANNELS
    • NMDA RECEPTOR
    • CLONING
    • GENES
    • CLASSIFICATION
    • EXPRESSION

    Cite this

    Collingridge, Graham L. ; Olsen, Richard W. ; Peters, John ; Spedding, Michael. / A nomenclature for ligand-gated ion channels. In: Neuropharmacology. 2009 ; Vol. 56, No. 1. pp. 25.
    @article{26a2a219007a40768c558e4d96916ad8,
    title = "A nomenclature for ligand-gated ion channels",
    abstract = "The ligand-gated ion channels that participate in fast synaptic transmission comprise the nicotinic acetylcholine, 5-hydroxytryptamine(3) (5-HT3), gamma-aminobutyric acid(A) (GABA(A)), glycine, ionotropic glutamate and P2X receptor families. A consistent and systematic nomenclature for the individual subunits that comprise these receptors and the receptors that result from their co-assembly is highly desirable. There is also a need to develop criteria that aid in deciding which of the vast number of heteromeric combinations of subunits that can be assembled in heterologous expression systems in vitro, are known, or likely. to exist as functional receptors in vivo. The aim of this short article is to summarize the progress being made by the nomenclature committee of IUPHAR (NC-IUPHAR) in formulating recommendations that attempt to address these issues. (C) 2008 Elsevier Ltd. All rights reserved.",
    keywords = "Ligand-gated ion channels, Nomenclature, UNION-OF-PHARMACOLOGY, GLUTAMATE RECEPTOR SUBUNIT, INTERNATIONAL-UNION, MOLECULAR RELATIONSHIPS, POTASSIUM CHANNELS, NMDA RECEPTOR, CLONING, GENES, CLASSIFICATION, EXPRESSION",
    author = "Collingridge, {Graham L.} and Olsen, {Richard W.} and John Peters and Michael Spedding",
    year = "2009",
    month = "1",
    doi = "10.1016/j.neuropharm.2008.06.063",
    language = "English",
    volume = "56",
    pages = "25",
    journal = "Neuropharmacology",
    issn = "0028-3908",
    publisher = "Elsevier",
    number = "1",

    }

    A nomenclature for ligand-gated ion channels. / Collingridge, Graham L.; Olsen, Richard W.; Peters, John; Spedding, Michael.

    In: Neuropharmacology, Vol. 56, No. 1, 01.2009, p. 25.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - A nomenclature for ligand-gated ion channels

    AU - Collingridge, Graham L.

    AU - Olsen, Richard W.

    AU - Peters, John

    AU - Spedding, Michael

    PY - 2009/1

    Y1 - 2009/1

    N2 - The ligand-gated ion channels that participate in fast synaptic transmission comprise the nicotinic acetylcholine, 5-hydroxytryptamine(3) (5-HT3), gamma-aminobutyric acid(A) (GABA(A)), glycine, ionotropic glutamate and P2X receptor families. A consistent and systematic nomenclature for the individual subunits that comprise these receptors and the receptors that result from their co-assembly is highly desirable. There is also a need to develop criteria that aid in deciding which of the vast number of heteromeric combinations of subunits that can be assembled in heterologous expression systems in vitro, are known, or likely. to exist as functional receptors in vivo. The aim of this short article is to summarize the progress being made by the nomenclature committee of IUPHAR (NC-IUPHAR) in formulating recommendations that attempt to address these issues. (C) 2008 Elsevier Ltd. All rights reserved.

    AB - The ligand-gated ion channels that participate in fast synaptic transmission comprise the nicotinic acetylcholine, 5-hydroxytryptamine(3) (5-HT3), gamma-aminobutyric acid(A) (GABA(A)), glycine, ionotropic glutamate and P2X receptor families. A consistent and systematic nomenclature for the individual subunits that comprise these receptors and the receptors that result from their co-assembly is highly desirable. There is also a need to develop criteria that aid in deciding which of the vast number of heteromeric combinations of subunits that can be assembled in heterologous expression systems in vitro, are known, or likely. to exist as functional receptors in vivo. The aim of this short article is to summarize the progress being made by the nomenclature committee of IUPHAR (NC-IUPHAR) in formulating recommendations that attempt to address these issues. (C) 2008 Elsevier Ltd. All rights reserved.

    KW - Ligand-gated ion channels

    KW - Nomenclature

    KW - UNION-OF-PHARMACOLOGY

    KW - GLUTAMATE RECEPTOR SUBUNIT

    KW - INTERNATIONAL-UNION

    KW - MOLECULAR RELATIONSHIPS

    KW - POTASSIUM CHANNELS

    KW - NMDA RECEPTOR

    KW - CLONING

    KW - GENES

    KW - CLASSIFICATION

    KW - EXPRESSION

    U2 - 10.1016/j.neuropharm.2008.06.063

    DO - 10.1016/j.neuropharm.2008.06.063

    M3 - Article

    C2 - 18655795

    VL - 56

    SP - 25

    JO - Neuropharmacology

    JF - Neuropharmacology

    SN - 0028-3908

    IS - 1

    ER -